The role of bariatric surgery to treat diabetes: current challenges and perspectives
- PMID: 28797248
- PMCID: PMC5553790
- DOI: 10.1186/s12902-017-0202-6
The role of bariatric surgery to treat diabetes: current challenges and perspectives
Abstract
Bariatric surgery is emerging as a powerful weapon against severe obesity and type 2 diabetes mellitus (T2DM). Given its role in metabolic regulation, the gastrointestinal tract constitutes a meaningful target to treat T2DM, especially in light of accumulating evidence that surgery with gastrointestinal manipulations may result in T2DM remission (metabolic surgery). The major mechanisms mediating the weight loss-independent effects of bariatric surgery comprise effects on tissue-specific insulin sensitivity, β-cell function and incretin responses, changes in bile acid composition and flow, modifications of gut microbiota, intestinal glucose metabolism and increased brown adipose tissue metabolic activity. Shorter T2DM duration, better preoperative glycemic control and profound weight loss, have been associated with higher rates of T2DM remission and lower risk of relapse. In the short and medium term, a significant amount of weight is lost, T2DM may completely regress, and cardiometabolic risk factors are dramatically improved. In the long term, metabolic surgery may achieve durable weight loss, prevent T2DM and cancer, improve overall glycemic control while leading to significant rates of T2DM remission, and reduce total and cause-specific mortality. The gradient of efficacy for weight loss and T2DM remission comparing the four established surgical procedures is biliopancreatic diversion >Roux-en-Y gastric bypass >sleeve gastrectomy >laparoscopic adjustable gastric banding. According to recently released guidelines, bariatric surgery should be recommended in diabetic patients with class III obesity, regardless of their level of glycemic control, and patients with class II obesity with inadequately controlled T2DM despite lifestyle and optimal medical therapy. Surgery should also be considered in patients with class I obesity and inadequately controlled hyperglycemia despite optimal medical treatment.
Keywords: Bariatric surgery; Diabetes remission; Metabolic surgery; Obesity; Type 2 diabetes mellitus.
Conflict of interest statement
Ethics approval and consent to participate
Not applicable
Consent for publication
Not applicable
Competing interests
AK is Associate Editor for BMC Endocrine Diseases.
SL is Section Editor for BMC Endocrine Diseases.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Similar articles
-
[Interpretation of the International Joint Statement on Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes].Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Apr 25;20(4):372-377. Zhonghua Wei Chang Wai Ke Za Zhi. 2017. PMID: 28440515 Chinese.
-
Neuro-modulation and bariatric surgery for type 2 diabetes mellitus.Int J Clin Pract Suppl. 2010 Feb;(166):53-8. doi: 10.1111/j.1742-1241.2009.02279.x. Int J Clin Pract Suppl. 2010. PMID: 20377665 Review.
-
Remission of Type 2 Diabetes Mellitus in Patients After Different Types of Bariatric Surgery: A Population-Based Cohort Study in the United Kingdom.JAMA Surg. 2015 Dec;150(12):1126-33. doi: 10.1001/jamasurg.2015.2398. JAMA Surg. 2015. PMID: 26422580
-
Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus.Ann Surg. 2013 Oct;258(4):628-36; discussion 636-7. doi: 10.1097/SLA.0b013e3182a5034b. Ann Surg. 2013. PMID: 24018646 Free PMC article.
-
[Contemporary overview of the bariatric-metabolic surgery].Rozhl Chir. 2012 Jan;91(1):5-11. Rozhl Chir. 2012. PMID: 22746072 Review. Czech.
Cited by
-
Bariatric surgery and diabetes: Current challenges and perspectives.World J Diabetes. 2024 Aug 15;15(8):1692-1703. doi: 10.4239/wjd.v15.i8.1692. World J Diabetes. 2024. PMID: 39192861 Free PMC article. Review.
-
Longitudinal Profiling of Fasting Plasma Metabolome in Response to Weight-Loss Interventions in Patients with Morbid Obesity.Metabolites. 2024 Feb 10;14(2):116. doi: 10.3390/metabo14020116. Metabolites. 2024. PMID: 38393008 Free PMC article.
-
Research progress on the relationship between bile acid metabolism and type 2 diabetes mellitus.Diabetol Metab Syndr. 2023 Nov 17;15(1):235. doi: 10.1186/s13098-023-01207-6. Diabetol Metab Syndr. 2023. PMID: 37978556 Free PMC article. Review.
-
Twelve-Month Outcomes in Patients with Obesity Following Bariatric Surgery-A Single Centre Experience.Nutrients. 2023 Feb 23;15(5):1134. doi: 10.3390/nu15051134. Nutrients. 2023. PMID: 36904134 Free PMC article.
-
Personalized Type 2 Diabetes Management: An Update on Recent Advances and Recommendations.Diabetes Metab Syndr Obes. 2022 Feb 4;15:281-295. doi: 10.2147/DMSO.S331654. eCollection 2022. Diabetes Metab Syndr Obes. 2022. PMID: 35153495 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials